List of articles in "Drug" category - Page 8

OX1001 (saquinavir-NO) is an experimental drug being developed by OncoNOx currently undergoing clinical studies and investigations for the treatment of cancer. OX1001 is a nitrate ester analog of the approved […]

SB-243213 is a research chemical which acts as a selective inverse agonist for the 5HT2C receptor and has anxiolytic effects. It has better than 100x selectivity for 5-HT2C over all […]

Sodium nitroprusside is an inorganic compound with the formula Na2[Fe(CN)5NO] usually encountered as the dihydrate Na2[Fe(CN)5NO]·2H2O. This red-colored sodium salt dissolves in water ethanol to give solutions containing the free […]

25CN-NBOH (or NBOH-2C-CN) is a compound indirectly derived from the phenethylamine series of hallucinogens which was discovered in 2011 by Martin Hansen at the University of Copenhagen. This compound is […]

Teneligliptin (INN; trade name Tenelia) is a pharmaceutical drug for the treatment of type 2 diabetes mellitus. It is approved for use in Japan. It belongs to the class of […]

Radotinib (INN; trade name Supect) is a drug for the treatment of some types of cancer. It is approved in Korea for use as a second-line treatment of chronic myeloid […]

Anagliptin (INN; trade name Suiny) is a pharmaceutical drug for the treatment of type 2 diabetes mellitus. It is approved for use in Japan. It belongs to the class of […]

3-Bromocytisine is a derivative of the toxic alkaloid cytisine that acts as a highly potent agonist at neural nicotinic acetylcholine receptors binding primarily to the α4β2 and α7 subtypes. 3-Bromocytisine […]

9-Carboxymethoxymethylguanine (CMMG) is a compound which is known as the principal metabolite of the antiviral drug acyclovir (and its prodrug valacyclovir) and has been suggested as the causative agent in […]

TRV130 is an opioid drug that is under evaluation in human clinical trials for the treatment of acute severe pain.It is a functionally selective μ-opioid receptor agonist developed by Trevena […]